Structural Analysis and Caco-2 Cell Permeability of the Celiac-Toxic A-Gliadin Peptide 31–55
- 27 January 2013
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 61 (5) , 1088-1096
Abstract
Celiac disease is a chronic enteropathy caused by the ingestion of wheat gliadin and other cereal prolamines. The synthetic peptides 31–43 (P31–43) and 31–49 (P31–49) from A-gliadin are considered to be model peptides for studying innate immunity in celiac disease. Our previous study demonstrated that P31–43 and P31–49 are encrypted within peptide 31–55 (P31–55), which is naturally released from gastropancreatic digestion and is not susceptible to hydrolysis by brush border membrane enzymes. Here, we analyzed the permeability of P31–55 through the epithelial cell layer of confluent Caco-2 cells using high-performance liquid chromatography, mass spectrometry, and fluorescence-activated cell sorting. Twenty-three percent of the P31–55 added to the apical chamber was transported to the basolateral chamber after 4 h of incubation without being degraded by hydrolysis. Treatment of Caco-2 cells with whole gliadin digests extracted from a common wheat cultivar increased the epithelial P31–55 translocation by approximately 35%. Moreover, we observed an atypical chromatographic profile consisting of a double peak. Chromatography using different column temperatures and circular dichroism highlighted the presence of more conformational structures around the amide bond of the two adjacent prolines 38 and 39. These findings confirm that P31–55 is gastrointestinally resistant and is permeable across a Caco-2 monolayer. Moreover, we hypothesize that the various conformations of P31–55 may play a role in the activation of innate immunity.Keywords
This publication has 45 references indexed in Scilit:
- Interferon-γ Released by Gluten-Stimulated Celiac Disease-Specific Intestinal T Cells Enhances the Transepithelial Flux of Gluten PeptidesThe Journal of Pharmacology and Experimental Therapeutics, 2009
- Growth factor-like activity of gliadin, an alimentary protein: implications for coeliac diseaseGut, 2007
- Chemistry of gluten proteinsFood Microbiology, 2007
- Adaptive and innate immune responses in celiac diseaseImmunology Letters, 2005
- The immune recognition of gluten in coeliac diseaseClinical and Experimental Immunology, 2005
- Intestinal digestive resistance of immunodominant gliadin peptidesAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2002
- Structural Basis for Gluten Intolerance in Celiac SprueScience, 2002
- The Intestinal T Cell Response to α-Gliadin in Adult Celiac Disease Is Focused on a Single Deamidated Glutamine Targeted by Tissue TransglutaminaseJournal of Experimental Medicine, 2000
- Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac diseaseNature Medicine, 1998
- Cereal chemistry, molecular biology, and toxicity in coeliac disease.Gut, 1991